AccuStem Sciences, Inc.
ACUT
$0.55
$0.1330.95%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.37M | 1.19M | 1.48M | 1.60M | 1.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.51M | 1.38M | 1.65M | 1.74M | 2.05M |
| Operating Income | -1.51M | -1.38M | -1.65M | -1.74M | -2.05M |
| Income Before Tax | -1.51M | -1.38M | -1.65M | -1.74M | -2.05M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.51 | -1.38 | -1.65 | -1.74 | -2.05 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.51M | -1.38M | -1.65M | -1.74M | -2.05M |
| EBIT | -1.51M | -1.38M | -1.65M | -1.74M | -2.05M |
| EBITDA | -1.50M | -1.38M | -1.65M | -1.74M | -2.05M |
| EPS Basic | -0.13 | -0.12 | -0.15 | -0.15 | -0.18 |
| Normalized Basic EPS | -0.08 | -0.08 | -0.09 | -0.10 | -0.11 |
| EPS Diluted | -0.13 | -0.12 | -0.15 | -0.15 | -0.18 |
| Normalized Diluted EPS | -0.08 | -0.08 | -0.09 | -0.10 | -0.11 |
| Average Basic Shares Outstanding | 45.74M | 45.39M | 45.39M | 45.39M | 45.39M |
| Average Diluted Shares Outstanding | 45.74M | 45.39M | 45.39M | 45.39M | 45.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |